Dave Hemink joined Velosity in 2021 as CEO, bringing over 30 years of experience in the medical device market space in a variety of sales, marketing, strategy, and leadership roles. Before joining Velosity, Hemink spent time at Boston Scientific, Cantel Medical, and C.R. Bard. He holds a BA in Business/Corporate Communications from California State University, Fresno, as well as an MBA from Northwestern University—Kellogg School of Management.